From diving into generative AI online to coaching senior executives, I've transformed my AI curiosity into actionable leadership expertise. My journey has led to building a community of 20,000+ engaged followers and delivering impactful AI keynotes and workshops to 3,000+ leaders globally. Drawing on 20+ years of senior leadership experience at global companies like Google, YouTube, Procter & Gamble, and Novartis, I now help leaders in medium and large organizations turn AI from a buzzword into a business accelerator.
Kaity Kalkbrenner is a healthcare analytics and strategy leader with more than 15 years of experience helping life sciences organizations turn data into strategic advantage. She has been an active shaper of AI enablement at Real Chemistry and across the healthcare communications industry, advancing how insight, analytics, and technology drive decision‑making. Today, Kaity leads Real Chemistry’s Swiss office, bringing the firm’s global capabilities to both local and international clients navigating complex scientific and commercial challenges.
GeorgPirmin Meyer, MD, is Chief International Officer at Nuvalent, where he leads international strategy for precisely targeted cancer therapies. He is a global biopharma executive with more than 20 years of leadership experience spanning oncology, rare diseases, commercial launches, market access, P&L management, and international organization building. Previously, he served as SVP & Head of International at Blueprint Medicines, building and leading its international business across Europe and other global markets. He also brings senior leadership experience from Vertex Pharmaceuticals, Amgen, and Sanofi, and serves as an Independent Board Director at RDP Pharma, and is an Ambassador/Vice-President of Life Science Cares Switzerland (LSCS)
From navigating an era of knowledge abundance to earning greater trust, attention and engagement, discover the shifts, pressures and opportunities set to reshape pharma marketing in 2027
Three forces - the new wave of MFN-style US pricing deals, China’s rapid ascent to roughly a third of the world’s innovative pipeline, and AI’s acceleration of R&D and commercial execution — are redrawing where pharma value is created and captured. I would benchmark how CH can potentially respond, then close with a practical playbook for leaders based here.
Hear from a leading clinician on the realities of where artificial intelligence can genuinely support clinicians. Focusing on endometriosis ultrasound, this session will explore what AI can do now and where the complexities of women’s health make implementation far more challenging.
Why meaningful AI adoption starts at the top, and what leaders need to understand, communicate and champion to turn AI ambition into real-world adoption.
Key learnings and what in store for the next meet-up
This event is for phama, biotech, and medtech professionals in Medical Affairs, Brand & Commercial, RWE & Data, Medical Communications/Publications, or Patient Engagement. If your role depends on making complex science resonate across stakeholders, this evening is for you.
National Museum Zürich. The striking ensemble comprises a fairy-tale castle with a stunning modern extension.
